Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04930159 · ClinicalTrials.gov registry record · NA
Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence
A NA study of Endometrial Cancer, sponsored by University of Washington.
- Active
- Registry status
- NA
- Development phase
- 252
- Enrollment target
- 11
- Study locations
NCT04930159: Active NA study of Endometrial Cancer, sponsored by University of Washington.
NCT04930159 is a NA study of Endometrial Cancer that is active but no longer recruiting, run by University of Washington. The registered enrollment target is 252 participants, below the 523-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (52% lower). The trial reports 11 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04930159, a NA study of Endometrial Cancer, is active but no longer recruiting, sponsored by University of Washington.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 252 participants
- Enrollment target
- 11
- Study locations
Study Summary
The SISTER study is a randomized trial, looking at various modalities of social support for Black patients undergoing treatment for endometrial cancer. There are three study arms: group support, 1:1 peer support, and enhanced usual care. The primary outcome is treatment completion, and the secondary outcome is social isolation.
Primary Outcome
Relative dose is the ratio of actual-to-expected total dose of treatment received. The calculation of expected total dose will be made from the baseline treatment recommendation data collected at enrollment.
Conditions Studied
Interventions
- BEHAVIORAL Facilitated group support
- BEHAVIORAL 1:1 Peer Support
Study Locations (11)
Maryland
- Johns Hopkins University - Baltimore
- MedStar Health Research Institute - Columbia
Alabama
- University of Alabama - Birmingham
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Florida
- University of Miami - Miami
Illinois
- The University of Chicago - Chicago
Louisiana
- Louisiana State University - New Orleans - New Orleans
New York
- Weill Cornell Medicine - New York
North Carolina
- University of North Carolina - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2030-10-31 |
| Phase | NA |
What the registry record for NCT04930159 still lists
NCT04930159 is an interventional study that assigns participants to a tested intervention. The registered 252 participants enrollment target is mid-sized for trials with a published cap, below the 523-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (52% lower).
The record links to 1 condition, with Endometrial Cancer appearing as the primary indexed condition, and to 2 interventions - of which Facilitated group support is the first listed.
NCT04930159 lists 11 locations in 10 states (Maryland, Alabama, Arkansas).
Frequently Asked Questions
What is clinical trial NCT04930159 about?
NCT04930159 is a clinical study titled "Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence". The SISTER study is a randomized trial, looking at various modalities of social support for Black patients undergoing treatment for endometrial cancer. There are three study arms: group support, 1:1 peer support, and enhanced usual care. The primary outcome is treatment completion, and the secondary...
What is the current status of trial NCT04930159?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 252 participants. The study started on 2021-09-01. Estimated completion is 2030-10-31.
What conditions does trial NCT04930159 study?
This clinical trial studies the following conditions: Endometrial Cancer.
What interventions are being tested in trial NCT04930159?
The interventions under investigation include: Facilitated group support (BEHAVIORAL), 1:1 Peer Support (BEHAVIORAL).
Who is sponsoring clinical trial NCT04930159?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04930159 being conducted?
This trial has 11 study locations across Alabama, Arkansas, Florida, Illinois, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04930159's enrollment target sits among peer trials
252 59th of 181 higher than 123 of 181 other Endometrial Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Endometrial Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
-
A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer
RECRUITING · NA
-
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
RECRUITING · NA
-
Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT03941756 · 252 participants · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- NCT05384158 · 252 participants · NA
Valuation in Depressed Mood, Anhedonia, and Anxiety
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI